Avrika

Biotechnology Disinfectantsavrika.life

Avrika is a private biotechnology company founded in 2020 in Overland Park, Kansas, that develops biotechnology-based disinfecting products. The 11-50 employee firm operates under co-founder and CEO Tom Johnson with minimal public disclosure on products, customers, or funding.

Company typePrivate
Founded2020
HeadquartersOverland Park, United States
Headcount11–50
GTM typeB2B
OfferingHardware or Manufacturing

Avrika firmographics

Firmographics

Name: Avrika
Website: https://avrika.life
Company type: Private
Founded year: 2020
Operating status: Operating
Headcount range: 11–50 employees
Short description: Avrika is a private biotechnology company founded in 2020 in Overland Park, Kansas, that develops biotechnology-based disinfecting products. The 11-50 employee firm operates under co-founder and CEO Tom Johnson with minimal public disclosure on products, customers, or funding.
Ownership category
akta.pro rank

Avrika industry classification

Industry

Product category: Biotechnology Disinfectants
NAICS: Medicinal and Botanical Manufacturing (325411)
SIC: Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry: Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)

Keywords

Biotechnology solutions
Disinfecting products
Antimicrobial technology
Bioscience cleaning
Biotech sanitization

Where Avrika is headquartered

Location

Headquarters

HQ city: Overland Park
HQ country: United States
HQ region: North America

Markets served

Avrika business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Avrika product offering

Product offering

Core offering

Avrika creates and develops biotechnology solutions used to make disinfecting products. The company applies biological science methods to develop disinfecting products, operating as a small private biotech firm in Overland Park, Kansas, with 11–50 employees.

Differentiator

Problem solved

Functional benefit

Products and services

Biotechnology-based disinfecting products Disinfecting products developed using biotechnology solutions; intended for buyers needing effective sanitation and cleaning alternatives.

Companies that use Avrika

Customer profile

Ideal customer profiles1 record

Avrika technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Avrika competitors and assessment

Company assessment

Direct peers

Seventh Generation: Seventh Generation sells plant- and bio-based household and commercial cleaning and disinfection products, making it a comparable consumer-and-institutional eco-disinfectant brand.
Method Products: Method produces plant-based and biodegradable cleaning and disinfecting products for household and commercial buyers, comparable as a bio-leaning disinfectant and cleaning brand.
Bioesque Solutions: Bioesque Solutions develops botanical and bio-based professional disinfectants and cleaners, directly comparable to Avrika's biotechnology-based disinfection positioning across institutional and commercial channels.
PURE Bioscience: PURE Bioscience develops proprietary silver-based antimicrobial and disinfectant actives used in food safety and surface sanitation, comparable to Avrika as a smaller, IP-driven disinfectant technology company.
Contec: Contec manufactures cleanroom and critical-environment disinfectant wipes and solutions, a comparable specialty disinfectant formulator serving healthcare, life sciences, and industrial end markets.

Broad incumbents

Ecolab: Ecolab is a global leader in institutional cleaning, sanitization, and disinfection products and services, the dominant broad incumbent whose customer relationships and regulatory footprint Avrika would have to compete against.
Clorox: Clorox is a household-name disinfectant and cleaning-products incumbent with broad retail and institutional distribution, the benchmark incumbent in the consumer and commercial disinfectant category.
Reckitt Benckiser (Lysol): Reckitt's Lysol is the global leader in branded disinfectants, a broad incumbent setting the performance, regulatory, and marketing benchmark Avrika would have to differentiate against.
Diversey: Diversey (now part of Solenis) formulates and supplies professional cleaning, sanitizing, and disinfection products globally, a broad incumbent competing for the same institutional buyers Avrika would target.
STERIS: STERIS provides sterilization, disinfection, and infection-prevention products and services to healthcare and life-science customers, a broad incumbent in adjacent regulated disinfectant categories.

Market position

Customer concentration

Avrika financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Avrika leadership team

Management profile

Number of profiles

Profiles1 record

Avrika funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Avrika M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avrika

What does Avrika do?

When was Avrika founded?

Avrika was founded in 2020. It employs 11 to 50 people.

Where is Avrika based?

Avrika is headquartered in Overland Park, United States, in the North America region.

Who are Avrika's main competitors?

Direct peers on record are Seventh Generation, Method Products, Bioesque Solutions, PURE Bioscience and Contec. Broad incumbents are Ecolab, Clorox, Reckitt Benckiser (Lysol), Diversey and STERIS.

Does Avrika have an API?

No public API is recorded for Avrika.

What industry is Avrika in?

Avrika's product category is Biotechnology Disinfectants. Its primary akta.pro industry code is AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing. Its NAICS code is 325411 and its SIC code is 2836.